Total Voting Rights

Summary by AI BETAClose X

AstraZeneca PLC has announced that as of January 31, 2026, its issued share capital with voting rights comprises 1,550,944,612 ordinary shares, with no shares held in treasury, resulting in a total of 1,550,944,612 voting rights. This figure serves as the denominator for shareholders to determine their notification obligations under the UK Financial Conduct Authority's Disclosure and Transparency Rules regarding their interests in the company.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings